You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Head and neck cancers

Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck

  • Technology appraisal guidance
  • Reference number: TA145
  • Published:  25 June 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders Appendix A: provisional matrix of stakeholders
11 April 2011
(42.3 Kb 12 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 11 April 2011

Back to top